406 related articles for article (PubMed ID: 35889903)
1. Specific Strains of
Hu W; Gao W; Liu Z; Fang Z; Wang H; Zhao J; Zhang H; Lu W; Chen W
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889903
[TBL] [Abstract][Full Text] [Related]
2. Both living and dead Faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short-chain fatty acid production.
Hu W; Lu W; Li L; Zhang H; Lee YK; Chen W; Zhao J
J Sci Food Agric; 2021 Oct; 101(13):5563-5573. PubMed ID: 33709404
[TBL] [Abstract][Full Text] [Related]
3. Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats.
Lensu S; Pariyani R; Mäkinen E; Yang B; Saleem W; Munukka E; Lehti M; Driuchina A; Lindén J; Tiirola M; Lahti L; Pekkala S
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33105554
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical efficacy of novel human-origin
Yang M; Wang JH; Shin JH; Lee D; Lee SN; Seo JG; Shin JH; Nam YD; Kim H; Sun X
Front Endocrinol (Lausanne); 2023; 14():1220044. PubMed ID: 37711887
[TBL] [Abstract][Full Text] [Related]
5. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
6. Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways.
Wang G; Jiao T; Xu Y; Li D; Si Q; Hao J; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jul; 11(7):6115-6127. PubMed ID: 32573567
[TBL] [Abstract][Full Text] [Related]
7. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
Lee JE; Lee SM; Jung J
Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice.
Zhang Z; Chen X; Cui B
Food Funct; 2021 May; 12(10):4504-4518. PubMed ID: 33885128
[TBL] [Abstract][Full Text] [Related]
10.
Nguyen HT; Gu M; Werlinger P; Cho JH; Cheng J; Suh JW
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362221
[TBL] [Abstract][Full Text] [Related]
11. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
[TBL] [Abstract][Full Text] [Related]
12.
Li H; Wang XK; Tang M; Lei L; Li JR; Sun H; Jiang J; Dong B; Li HY; Jiang JD; Peng ZG
Gut Microbes; 2024; 16(1):2304159. PubMed ID: 38277137
[TBL] [Abstract][Full Text] [Related]
13.
Shin JH; Lee Y; Song EJ; Lee D; Jang SY; Byeon HR; Hong MG; Lee SN; Kim HJ; Seo JG; Jun DW; Nam YD
Front Microbiol; 2023; 14():1123547. PubMed ID: 37007480
[TBL] [Abstract][Full Text] [Related]
14. Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.
Kim S; Choi S; Dutta M; Asubonteng JO; Polunas M; Goedken M; Gonzalez FJ; Cui JY; Gyamfi MA
Biochem Pharmacol; 2021 Nov; 193():114698. PubMed ID: 34303710
[TBL] [Abstract][Full Text] [Related]
15. Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice.
Duan R; Huang K; Guan X; Li S; Xia J; Shen M; Sun Z; Yu Z
Food Chem Toxicol; 2022 Jun; 164():112948. PubMed ID: 35390440
[TBL] [Abstract][Full Text] [Related]
16. A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease.
Zhu X; Cai J; Wang Y; Liu X; Chen X; Wang H; Wu Z; Bao W; Fan H; Wu S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069055
[TBL] [Abstract][Full Text] [Related]
17. Gnotobiotic mice inoculated with Firmicutes, but not Bacteroidetes, deteriorate nonalcoholic fatty liver disease severity by modulating hepatic lipid metabolism.
Chen YH; Chiu CC; Hung SW; Huang WC; Lee YP; Liu JY; Huang YT; Chen TH; Chuang HL
Nutr Res; 2019 Sep; 69():20-29. PubMed ID: 31470288
[TBL] [Abstract][Full Text] [Related]
18. Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides.
Lindstad LJ; Lo G; Leivers S; Lu Z; Michalak L; Pereira GV; Røhr ÅK; Martens EC; McKee LS; Louis P; Duncan SH; Westereng B; Pope PB; La Rosa SL
mBio; 2021 Jun; 12(3):e0362820. PubMed ID: 34061597
[TBL] [Abstract][Full Text] [Related]
19. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
[TBL] [Abstract][Full Text] [Related]
20. The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids.
Xia F; Xiang S; Chen Z; Song L; Li Y; Liao Z; Ge B; Zhou B
Arch Biochem Biophys; 2021 Dec; 714():109080. PubMed ID: 34742934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
